From single gene analysis to single cell profiling: a new era for precision medicine.


Journal

Journal of experimental & clinical cancer research : CR
ISSN: 1756-9966
Titre abrégé: J Exp Clin Cancer Res
Pays: England
ID NLM: 8308647

Informations de publication

Date de publication:
05 Mar 2020
Historique:
received: 20 01 2020
accepted: 14 02 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 21 10 2020
Statut: epublish

Résumé

Molecular profiling of DNA and RNA has provided valuable new insights into the genetic basis of non-malignant and malignant disorders, as well as an increased understanding of basic mechanisms that regulate human disease. Recent technological advances have enabled the analyses of alterations in gene-based structure or function in a comprehensive, high-throughput fashion showing that each tumor type typically exhibits distinct constellations of genetic alterations targeting one or more key cellular pathways that regulate cell growth and proliferation, evasion of the immune system, and other aspects of cancer behavior. These advances have important implications for future research and clinical practice in areas as molecular diagnostics, the implementation of gene or pathway-directed targeted therapy, and the use of such information to drive drug discovery. The 1st international and 32nd Annual Conference of Italian Association of Cell Cultures (AICC) conference wanted to offer the opportunity to match technological solutions and clinical needs in the era of precision medicine.

Identifiants

pubmed: 32138788
doi: 10.1186/s13046-020-01549-3
pii: 10.1186/s13046-020-01549-3
pmc: PMC7059661
doi:

Types de publication

Congress

Langues

eng

Sous-ensembles de citation

IM

Pagination

48

Références

Oncotarget. 2015 Sep 22;6(28):26129-41
pubmed: 26305418
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
Nat Immunol. 2017 May;18(5):530-540
pubmed: 28288101
Nature. 2017 Dec 7;552(7683):116-120
pubmed: 29186113
Bioinformatics. 2019 Oct 1;35(19):3651-3662
pubmed: 30824909
J Exp Clin Cancer Res. 2018 Oct 30;37(1):262
pubmed: 30376854
Nat Rev Immunol. 2019 Apr;19(4):255-265
pubmed: 30816340
Nat Genet. 2011 Aug 28;43(10):1022-5
pubmed: 21874000
J Exp Clin Cancer Res. 2018 Mar 5;37(1):47
pubmed: 29506529
Int J Cancer. 2016 Jul 15;139(2):243-55
pubmed: 26789729
Leukemia. 2016 Jun;30(6):1263-72
pubmed: 26898188
Cancer Res. 2011 Jul 1;71(13):4617-27
pubmed: 21546571
Nature. 2017 Mar 2;543(7643):65-71
pubmed: 28199314
Vaccines (Basel). 2015 Jul 14;3(3):544-55
pubmed: 26350594
Nat Immunol. 2019 Jul;20(7):783-792
pubmed: 31213714
J Clin Oncol. 2018 Oct 30;:JCO2018790352
pubmed: 30376426
J Allergy Clin Immunol. 2019 Jun;143(6):2120-2130
pubmed: 30578879
J Clin Pathol. 2019 Jan;72(1):38-45
pubmed: 30279174
J Immunother Cancer. 2018 Jun 5;6(1):50
pubmed: 29871670
Oncogene. 2020 Jan;39(4):754-766
pubmed: 31570788
Carcinogenesis. 2015 Jan;36(1):76-81
pubmed: 25380601
Oncogene. 2016 May 19;35(20):2592-601
pubmed: 26300006
Blood. 2017 Mar 23;129(12):1595-1606
pubmed: 28159740
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Cell Death Dis. 2019 Jul 11;10(7):534
pubmed: 31296838
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E440-9
pubmed: 25605905
Curr Pharm Des. 2018;24(32):3818-3828
pubmed: 30398105
J Endocrinol. 2018 Mar;236(3):R161-R167
pubmed: 29321190
J Hematol Oncol. 2019 Nov 27;12(1):125
pubmed: 31775797
Mol Clin Oncol. 2019 Jul;11(1):81-90
pubmed: 31289683
Leukemia. 2019 Feb;33(2):487-498
pubmed: 30120376
Nat Med. 2017 Jun;23(6):692-702
pubmed: 28504724
Science. 2019 Dec 20;366(6472):1473-1480
pubmed: 31699882
Leukemia. 2018 Dec;32(12):2604-2616
pubmed: 29789651
Oncoimmunology. 2015 Aug 31;5(3):e1086862
pubmed: 27141343
CA Cancer J Clin. 2019 Sep;69(5):402-429
pubmed: 31283845
Br J Cancer. 2017 Mar 14;116(6):802-810
pubmed: 28170370
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7356-7361
pubmed: 29941555
Pharmacogenomics. 2019 Sep;20(14):1049-1059
pubmed: 31559917
Cancer. 2020 Jan 1;126(1):22-25
pubmed: 31503330
J Clin Pathol. 2018 Dec;71(12):1123-1126
pubmed: 30315134
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
J Clin Invest. 2015 Sep;125(9):3335-7
pubmed: 26325031
Lancet Oncol. 2013 May;14(6):448-9
pubmed: 23583605
Cell Death Differ. 2017 Oct;24(10):1694-1704
pubmed: 28665402
Trends Immunol. 2008 Jun;29(6):256-62
pubmed: 18457994

Auteurs

Maria Teresa Di Martino (MT)

Department of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy. teresadm@unicz.it.

Stefania Meschini (S)

National Center for Drug Research and Evaluation, National Institute of Health, Rome, Italy.

Katia Scotlandi (K)

IRCCS Istituto Ortopedico Rizzoli, Experimental Oncology Lab, Bologna, Italy.

Chiara Riganti (C)

Department of Oncology, University of Torino, Turin, Italy.

Enrico De Smaele (E)

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Francesca Zazzeroni (F)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Massimo Donadelli (M)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biochemistry, University of Verona, Verona, Italy.

Carlo Leonetti (C)

UOSD SAFU, IRCCS-Regina Elena National Cancer Institute, Rome, Italy. carlo.leonetti@ifo.gov.it.

Michele Caraglia (M)

Department of Precision Medicine, University of Campania "L. Vanvitelli", Naples and Biogem Scarl, Institute of Genetic Research, Laboratory of Precision and Molecular Oncology, Ariano Irpino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH